AbstractIn human brain the Aβ peptide is produced mainly by neurons and the overexpression of amyloid precursor protein (APP) that involves an increase in Aβ secretion, has been observed in some areas of the Alzheimer's disease patients brain. We have generated two stably transfected human neuroblastoma lines which overexpress APP; both of them secreted Aβ and showed morphological changes and cell death with apoptotic program characteristics. Interestingly, coculture experiments with the untransfected human neuroblastoma cell line showed that the Aβ peptide was not responsible for the death in those cell lines; additionally, we indicate that upon cell death, Aβ peptide is secreted into cell medium
AbstractConverging evidence suggests that the accumulation of cerebral amyloid β-protein (Aβ) in Alz...
AbstractThe classic neuropathological diagnostic markers for AD are amyloid plaques and neurofibrill...
AbstractFor 20years the amyloid cascade hypothesis of Alzheimer disease (AD) has placed the amyloid-...
AbstractIn human brain the Aβ peptide is produced mainly by neurons and the overexpression of amyloi...
AbstractThe amyloid-β precursor protein (APP) is directly and efficiently cleaved by caspases during...
Alzheimer’s disease (AD), identified over 100 years ago and intensively studied since the 1970s, has...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder. Although the pathogenesis of A...
The deposition in the brain of the 4 kDa beta-amyloid peptide (betaA4), from amyloid precursor prote...
AbstractIn vitro and in vivo studies have shown that β-amyloid peptide induces neuronal cell death. ...
One of the major neuropathological hallmarks of Alzheimer's disease is the presence of senile plaque...
A large body of evidence supports the Amyloid β (Aβ) cascade hypothesis underlying neurodegeneration...
In vitro and in vivo studies have shown that beta-amyloid peptide induces neuronal cell death. To ex...
AbstractThe two histopathological signatures of Alzheimer's disease (AD) are amyloid plaques and neu...
Amyloid-β 40 peptides [Aβ1-40 (Aβ40)] are present within amyloid plaques in the brains of patients w...
Evidence for a central role of amyloid β-protein (Aβ) in the genesis of Alzheimer’s disease (AD) has...
AbstractConverging evidence suggests that the accumulation of cerebral amyloid β-protein (Aβ) in Alz...
AbstractThe classic neuropathological diagnostic markers for AD are amyloid plaques and neurofibrill...
AbstractFor 20years the amyloid cascade hypothesis of Alzheimer disease (AD) has placed the amyloid-...
AbstractIn human brain the Aβ peptide is produced mainly by neurons and the overexpression of amyloi...
AbstractThe amyloid-β precursor protein (APP) is directly and efficiently cleaved by caspases during...
Alzheimer’s disease (AD), identified over 100 years ago and intensively studied since the 1970s, has...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder. Although the pathogenesis of A...
The deposition in the brain of the 4 kDa beta-amyloid peptide (betaA4), from amyloid precursor prote...
AbstractIn vitro and in vivo studies have shown that β-amyloid peptide induces neuronal cell death. ...
One of the major neuropathological hallmarks of Alzheimer's disease is the presence of senile plaque...
A large body of evidence supports the Amyloid β (Aβ) cascade hypothesis underlying neurodegeneration...
In vitro and in vivo studies have shown that beta-amyloid peptide induces neuronal cell death. To ex...
AbstractThe two histopathological signatures of Alzheimer's disease (AD) are amyloid plaques and neu...
Amyloid-β 40 peptides [Aβ1-40 (Aβ40)] are present within amyloid plaques in the brains of patients w...
Evidence for a central role of amyloid β-protein (Aβ) in the genesis of Alzheimer’s disease (AD) has...
AbstractConverging evidence suggests that the accumulation of cerebral amyloid β-protein (Aβ) in Alz...
AbstractThe classic neuropathological diagnostic markers for AD are amyloid plaques and neurofibrill...
AbstractFor 20years the amyloid cascade hypothesis of Alzheimer disease (AD) has placed the amyloid-...